Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ACM 001

Next Previous
X
Search
Drug Profile

ACM 001

Alternative Names: ACM-001 - ACM Bioscience; ACM-SARS-CoV-2-beta ACM-CpG vaccine; COVID-19 subunit vaccine - ACM Biosciences

Latest Information Update: 22 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ACM Biosciences
  • Class COVID-19 vaccines; Protein vaccines; Subunit vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - COVID 2019 infections

Highest Development Phases

  • Phase I COVID 2019 infections

Most Recent Events

  • 22 Sep 2023 Phase-I clinical trials in COVID-2019 infections (Prevention) (SC) (ACM Biosciences pipeline, September 2023)
  • 26 Jul 2022 ACM 001 is available for licensing as of 26 Jul 2022. https://acmbiolabs.com/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top